Pharmafile Logo
T40 2022 Cover
Diversity, Equity and Inclusion
Communiqué 53 Cover Image
- PMLiVE

GlycoVaxyn

- PMLiVE

GSK hands back rights to ChemoCentryx drug

Investigational IBD treatment vercirnon disappoints in phase III

- PMLiVE

FDA guidance clears path for Advair generics

Offers simplified process for potential copies of GSK’s asthma and COPD drug

- PMLiVE

US turns spotlight on GSK bribery allegations

Department of Justice to investigate whether pharma giant contravened foreign corruption act

- PMLiVE

FDA queries safety of GSK’s Anoro for COPD

Adviser questions the drug's cardiovascular profile

- PMLiVE

GSK sells Lucozade and Ribena for £1.35bn

Suntory Beverage & Food acquires consumer brands

- PMLiVE

Setback for GSK as melanoma vaccine misses targets

Cancer immunotherapy disappoints in phase III

- PMLiVE

GSK splits media account between two agencies

GroupM and Omnicom are the winners in GSK’s latest consolidation

China flag thumb

GSK blamed for employee bribes in China

Xinhua news agency claims company was complicit in the payment of kickbacks to doctors

- PMLiVE

GSK melanoma therapy Tafinlar cleared in EU

Follows approvals for skin cancer drug in US, Canada and Australia

- PMLiVE

GSK gets OK for second quadrivalent flu vaccine in US

FDA approves Flulaval Quadrivalent

- PMLiVE

GSK’s Tyverb cleared for use alongside Herceptin

Combination already approved in the Philippines, Russia and Thailand

- PMLiVE

ViiV gets US nod for HIV drug dolutegravir

GSK and Pfizer joint venture on course for first drug launch

Subscribe to our email news alerts

Latest jobs from #PharmaRole

Latest content

Latest intelligence

Quick links